Top

European Journal of Trauma and Emergency Surgery

Published in:

Open Access 01-10-2018 | Review Article

Autologous cell-based therapy for treatment of large bone defects: from bench to bedside

Authors: R. Verboket, M. Leiblein, C. Seebach, C. Nau, M. Janko, M. Bellen, H. Bönig, D. Henrich, I. Marzi

Published in: European Journal of Trauma and Emergency Surgery | Issue 5/2018

Abstract

Objectives

Reconstruction of long segmental bone defects is demanding for patients and surgeons, and associated with long-term treatment periods and substantial complication rates in addition to high costs. While defects up to 4–5 cm length might be filled up with autologous bone graft, heterologous bone from cadavers, or artificial bone graft substitutes, current options to reconstruct bone defects greater than 5 cm consist of either vascularized free bone transfers, the Masquelet technique or the Ilizarov distraction osteogenesis. Alternatively, autologous cell transplantation is an encouraging treatment option for large bone defects as it eliminates problems such as limited autologous bone availability, allogenic bone immunogenicity, and donor-site morbidity, and might be used for stabilizing loose alloplastic implants.

Methods

The authors show different cell therapies without expansion in culture, with ex vivo expansion and cell therapy in local bone defects, bone healing and osteonecrosis. Different kinds of cells and scaffolds investigated in our group as well as in vivo transfer studies and BMC used in clinical phase I and IIa clinical trials of our group are shown.

Results

Our research history demonstrated the great potential of various stem cell species to support bone defect healing. It was clearly shown that the combination of different cell types is superior to approaches using single cell types. We further demonstrate that it is feasible to translate preclinically developed protocols from in vitro to in vivo experiments and follow positive convincing results into a clinical setting to use autologous stem cells to support bone healing.

Cattaneo R, Catagni MA, Guerreschi F. Applications of the Ilizarov method in the humerus. Lengthenings and nonunions. Hand Clin. 1993;9:729–39.PubMed

Weiland AJ. Current concepts review: vascularized free bone transplants. J Bone Jt Surg. 1981;63:166–9.

Giannoudis PV, Faour O, Goff T, Kanakaris N, Dimitriou R. Masquelet technique for the treatment of bone defects: tips-tricks and future directions. Injury. 2011;42:591–8.PubMed

Khan Y, Yaszemski MJ, Mikos AG, Laurencin CT. Tissue engineering of bone: material and matrix considerations. J Bone Jt Surg. 2008;90(Suppl 1):36–42.

Vacanti J, Langer R, Upton J, Marler J. Transplantation of cells in matrices for tissue regeneration. Adv Drug Deliv Rev. 1998;33:165–82.PubMed

Jäger M, Hernigou P, Zilkens C, Herten M, Li X, Fischer J, et al. Cell therapy in bone healing disorders. Orthop Rev. 2010;2:20.

Jäger M, Jelinek E, Wess K, Scharfstadt A, Jacobson M, Kevy S, et al. Bone marrow concentrate: a novel strategy for bone defect treatment. Curr Stem Cell Res Ther. 2009;4:34–43.PubMed

Jäger M. Joint-preserving surgery for atraumatic avascular necrosis. Osteologie. 2010;19:29–35.

Hendrich C, Engelmaier F, Waertel G, Krebs R, Jäger M. Safety of autologous bone marrow aspiration concentrate transplantation: initial experiences in 101 patients. Orthop Rev. 2009;1:32.

10.

Kurkalli BG, Gurevitch O, Sosnik A, Cohn D, Slavin S. Repair of bone defect using bone marrow cells and demineralized bone matrix supplemented with polymeric materials. Curr Stem Cell Res Ther. 2010;5:49–56.PubMed

11.

Yoshimi R, Yamada Y, Ito K, Nakamura S, Abe A, Nagasaka T, et al. Self-assembling peptide nanofiber scaffolds, platelet-rich plasma, and mesenchymal stem cells for injectable bone regeneration with tissue engineering. J Craniofac Surg. 2009;20:1523–30.PubMed

12.

Marlovits S, Striessnig G, Kutscha-Lissberg F, Resinger C, Aldrian SM, Vécsei V, et al. Early postoperative adherence of matrix-induced autologous chondrocyte implantation for the treatment of full-thickness cartilage defects of the femoral condyle. Knee Surg Sports Traumatol Arthrosc. 2004;13:451–7.PubMed

13.

Marlovits S, Zeller P, Singer P, Resinger C, Vécsei V. Cartilage repair: generations of autologous chondrocyte transplantation. Eur J Radiol. 2006;57:24–31.

14.

Nöth U, Reichert J, Reppenhagen S, Steinert A, Rackwitz L, Eulert J, et al. Cell based therapy for the treatment of femoral head necrosis. Orthopade. 2007;36:466–71.PubMed

15.

Jäger M, Wild A, Lensing-Höhn S, Krauspe R. Influence of different culture solutions on osteoblastic differentiation in cord blood and bone marrow derived progenitor cells. Biomed Tech (Berl). 2003;48:241–4.

16.

Turnovcova K, Ruzickova K, Vanecek V, Sykova E, Jendelova P. Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media. Cytotherapy. 2009;11:874–85.PubMed

17.

Zilkens C, Lögters T, Bittersohl B, Krauspe R, Lensing-Höhn S, Jäger M. Spinning around or stagnation—what do osteoblasts and chondroblasts really like? Eur J Med Res BioMed Cent. 2010;15:35.

18.

Dahl J-A, Duggal S, Coulston N, Millar D, Melki J, Shahdadfar A, et al. Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. Int J Dev Biol. 2008;52:1033–42.PubMed

19.

Siddiqi S, Mills J, Matushansky I. Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomas. Curr Stem Cell Res Ther. 2010;5:63–73.PubMedPubMedCentral

20.

Giannini S, Buda R, Vannini F, Cavallo M, Grigolo B. One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop Relat Res. 2009;467:3307–20.PubMedPubMedCentral

21.

Connolly JF, Guse R, Tiedeman J, Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res. 1991;266:259–70.

22.

Hernigou PH, Mathieu G, Poignard A, Manicom O, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. J Bone Jt Surg. 2006;88:322–7.

23.

Hernigou P, Mathieu G, Poignard A, Manicom O, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions: surgical technique. JBJS Essent Surg Tech. 2006;os-88:322–7.

24.

Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: the diamond concept. Injury 2008 ed. 2007;38(Suppl 4):S3–6.

25.

Drosse I, Volkmer E, Capanna R, De Biase P, Mutschler W, Schieker M. Tissue engineering for bone defect healing: an update on a multi-component approach. Injury. 2008;39(Suppl 2):S9–20.PubMed

26.

Schmidmaier G, Wildemann B, Bail H, Lucke M, Fuchs T, Stemberger A, et al. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-β1) from a biodegradable poly(d,l-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone. 2001;28:341–50.PubMed

27.

Schmidmaier G, Wildemann B, Heeger J, Gäbelein T, Flyvbjerg A, Bail HJ, et al. Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-β1. Bone. 2002;31:165–72.PubMed

28.

Zhang SJ, Zhang H, Wei YJ, Su WJ, Liao ZK, Hou M, et al. Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Cell Res. 2006;16:577–84.PubMed

29.

Zhang SJ, Zhang H, Hou M, Zheng Z, Zhou J, Su W, et al. Is it possible to obtain “true endothelial progenitor cells” by in vitro culture of bone marrow mononuclear cells? Stem Cells Dev. 2007;16:683–90.PubMed

30.

Assmus B. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106:3009–17.

31.

Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert RA, et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res. 2000;87:728–30.PubMed

32.

Henrich D, Hahn P, Wahl M, Wilhelm K, Dernbach E, Dimmeler S, et al. Serum derived from multiple trauma patients promotes the differentiation of endothelial progenitor cells in vitro: possible role of transforming growth factor-beta1 and vascular endothelial growth factor165. Shock. 2004;21:13–6.PubMed

33.

Henrich D, Seebach C, Wilhelm K, Marzi I. High dosage of simvastatin reduces TNF-alpha-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1beta in vitro. J Surg Res. 2007;142:13–9.PubMed

34.

Henrich D, Zimmer S, Seebach C, Frank J, Barker J, Marzi I. Trauma-activated polymorphonucleated leukocytes damage endothelial progenitor cells: probable role of CD11b/CD18-CD54 interaction and release of reactive oxygen species. Shock. 2011;36:216–22.PubMed

35.

Gehling UM, Ergün S, Schuch G, Schafhausen P, Kilic N, Schäfer B, et al. In vitro differentiation of endothelial cells (EC) from AC133-positive progenitor cells. Eur J Cancer. 1999;35:S103–4.

36.

Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95:952–8.PubMed

37.

Fuchs S, Hofmann A, Kirkpatrick CJ. Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells. Tissue Eng. 2007;13:2577–88.PubMed

38.

Dimmeler S, Assmus B, Hermann C, Haendeler J, Zeiher AM. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circulation Res. 1998;83:334–41.PubMed

39.

Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001;103:2885–90.PubMed

40.

Powerski MJ, Henrich D, Sander A, Wastl D, Ludwig K, Marzi I. CD133 + CD34 + stem cells are mobilized after musculoskeletal surgery and target endothelium activated by surgical wound fluid. Langenbeck’s Arch Surg. 2010;396:379–87.

41.

Janusz Powerski M, Henrich D, Wastl D, Sander A, Marzi I. Surgical wound fluid from elderly patients shows a dramatically reduced potential to stimulate in-vitro recruitment and differentiation of endothelial progenitor cells: role of VEGF-165 and TGF-β1. Wounds. 2010;22:204–11.PubMed

42.

Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230–47.

43.

Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.

44.

Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem. 1994;56:283–94.PubMed

45.

Seebach C, Henrich D, Tewksbury R, Wilhelm K, Marzi I. Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions. Calcif Tissue Int. 2007;80:294–300.PubMed

46.

Assmus B, Rolf A, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, et al. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail. 2010;3:89–96.PubMed

47.

Henrich D, Seebach C, Sterlepper E, Tauchmann C, Marzi I, Frank J. RIA reamings and hip aspirate: a comparative evaluation of osteoprogenitor and endothelial progenitor cells. Injury. 2010;41(Suppl 2):S62–8.PubMed

48.

Kuçi Z, Kuçi S, Zircher S, Koller S, Schubert R, Bonig H, et al. Mesenchymal stromal cells derived from CD271 + bone marrow mononuclear cells exert potent allosuppressive properties. Cytotherapy. 2011;13:1193–204.PubMed

49.

Henrich D, Verboket R, Schaible A, Kontradowitz K, Oppermann E, Brune JC, et al. Characterization of bone marrow mononuclear cells on biomaterials for bone tissue engineering in vitro. Biomed Res Int Hindawi. 2015;2015:1–12.

50.

Tormin A, Li O, Brune JC, Walsh S, Schütz B, Ehinger M, et al. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood Am Soc Hematol. 2011;117:5067–77.

51.

Pearson JD. Endothelial progenitor cells—hype or hope? J Thromb Haemost 2009;7:255–62.PubMed

52.

Kuçi S, Kuçi Z, Kreyenberg H, Deak E, Pütsch K, Huenecke S, et al. CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties. Haematol. 2010;95:651–9.

53.

Cuthbert R, Boxall SA, Tan HB, Giannoudis PV, McGonagle D, Jones E. Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use. Cytotherapy. 2012;14:431–40.PubMed

54.

Jeon O, Song SJ, Bhang SH, Choi C-Y, Kim MJ, Kim B-S. Additive effect of endothelial progenitor cell mobilization and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs. J Biomed Sci. 2007;14:323–30.PubMed

55.

Schmidmaier G, Herrmann S, Green J, Weber T, Scharfenberger A, Haas NP, et al. Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation. Bone. 2006;39:1156–63.PubMed

56.

Wenisch S, Trinkaus K, Hild A, Hose D, Herde K, Heiss C, et al. Human reaming debris: a source of multipotent stem cells. Bone. 2005;36:74–83.PubMed

57.

Henrich D, Nau C, Kraft S, Zollfrank M, Kontradowitz K, Oppermann E, et al. Effect of the harvest procedure and tissue site on the osteogenic function of and gene expression in human mesenchymal stem cells. Int J Mol Med. 2016;37:976–88.PubMedPubMedCentral

58.

Seebach C, Schultheiss J, Wilhelm K, Frank J, Henrich D. Comparison of six bone-graft substitutes regarding to cell seeding efficiency, metabolism and growth behaviour of human mesenchymal stem cells (MSC) in vitro. Injury. 2010;41:731–8.PubMed

59.

Schultheiss J, Seebach C, Henrich D, Wilhelm K, Barker JH, Frank J. Mesenchymal stem cell (MSC) and endothelial progenitor cell (EPC) growth and adhesion in six different bone graft substitutes. Eur J Trauma Emerg Surg. 2011;37:635–44.PubMed

60.

Henrich D, Wilhelm K, Warzecha J, Frank J, Barker J, Marzi I, et al. Human endothelial-like differentiated precursor cells maintain their endothelial characteristics when cocultured with mesenchymal stem cell and seeded onto human cancellous bone. Mediat Inflamm Hindawi. 2013;2013:364591–12.

61.

Eldesoqi K, Seebach C, Nguyen Ngoc C, Meier S, Nau C, Schaible A, et al. High calcium bioglass enhances differentiation and survival of endothelial progenitor cells, inducing early vascularization in critical size bone defects. Bhattacharya S, editor. PLoS One. 2013;8:e79058.PubMedPubMedCentral

62.

Seebach C, Henrich D, Kahling C, Wilhelm K, Tami AE, Alini M, et al. Endothelial progenitor cells and mesenchymal stem cells seeded onto beta-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats. Tissue Eng Part A. 2010;16:1961–70.PubMed

63.

Seebach C, Henrich D, Wilhelm K, Barker JH, Marzi I. Endothelial progenitor cells improve directly and indirectly early vascularization of mesenchymal stem cell-driven bone regeneration in a critical bone defect in rats. Cell Transpl. 2012;21:1667–77.

64.

Eldesoqi K, Henrich D, El-Kady AM, Sweify KM, Relja B, El-hady B. Improved bone formation by differentiated mesenchymal stem cells and endothelial progenitor cells seeded on high concentrated bioglass-polylactic acid composite in calvarial rat bone defect. J Stem Cell Res Dev Ther. 2015;2:1–7.

65.

Wang Y, Han Z-B, Song Y-P, Han ZC. Safety of mesenchymal stem cells for clinical application. Stem Cells Int Hindawi. 2012;2012:1–4.

66.

Jenkins CR, Shevchuk OO, Giambra V, Lam SH, Carboni JM, Gottardis MM, et al. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein. Exp Hematol. 2012;40:715–6.PubMed

67.

Janko M, Sahm J, Schaible A, Brune JC, Bellen M, Schröder K, et al. Comparison of three different types of scaffolds preseeded with human bone marrow mononuclear cells on the bone healing in a femoral critical size defect model of the athymic rat. J Tissue Eng Regen Med. 2017. https://doi.org/10.1002/term.2484. ISSN 1932-7005.PubMed

68.

Seebach C, Henrich D, Schaible A, Relja B, Jugold M, Bonig H, et al. Cell-based therapy by implanted human bone marrow-derived mononuclear cells improved bone healing of large bone defects in rats. Tissue Eng Part A. 2015;21:1565–78.PubMed

69.

Saxer F, Scherberich A, Todorov A, Studer P, Miot S, Schreiner S, et al. Implantation of stromal vascular fraction progenitors at bone fracture sites: from a rat model to a first-in-man study. Stem Cells. 2016;34:2956–66.PubMed

70.

Seebach C, Henrich D, Meier S, Nau C, Bonig H, Marzi I. Safety and feasibility of cell-based therapy of autologous bone marrow-derived mononuclear cells in plate-stabilized proximal humeral fractures in humans. J Transl Med BioMed Central. 2016;14:314.

71.

Ardjomandi N, Duttenhoefer F, Xavier S, Oshima T, Kuenz A, Sauerbier S. In vivo comparison of hard tissue regeneration with ovine mesenchymal stem cells processed with either the FICOLL method or the BMAC method. J Craniomaxillofac Surg. 2015;43:1177–83.PubMed

72.

Duttenhoefer F, Hieber SF, Stricker A, Schmelzeisen R, Gutwald R, Sauerbier S. Follow-up of implant survival comparing ficoll and bone marrow aspirate concentrate methods for hard tissue regeneration with mesenchymal stem cells in humans. BioRes Open Access. 2014;3:75–6.PubMedPubMedCentral

73.

Dimitriou R, Mataliotakis GI, Angoules AG, Kanakaris NK, Giannoudis PV. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury. 2011;42:S3–15.

74.

Carini F, Longoni S, Amosso E, Paleari J, Carini S, Porcaro G. Bone augmentation with TiMesh. autologous bone versus autologous bone and bone substitutes. A systematic review. Ann Stomatol (Roma). 2014;5:27–36.

75.

Jäger M, Herten M, Fochtmann U, Fischer J, Hernigou P, Zilkens C, et al. Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res. 2011;29:173–80.PubMed

76.

Lokiec F, Ezra E, Khermosh O, Wientroub S. Simple bone cysts treated by percutaneous autologous marrow grafting. A preliminary report. J Bone Jt Surg Br. 1996;78:934–7.

77.

Köse N, Gokturk E, Turgut A, et al. Percutaneous autologous bone marrow grafting for simple bone cysts. Bull Hosp Jt Dis. 1999;58:105–10.PubMed

78.

Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002;405:14–23.

79.

Rougraff BT, Kling TJ. Treatment of active unicameral bone cysts with percutaneous injection of demineralized bone matrix and autogenous bone marrow. J Bone Jt Surg Am. 2004;84-A:921–9.

80.

Chang CH, Stanton RP, Glutting J. Unicameral bone cysts treated by injection of bone marrow or methylprednisolone. J Bone Jt Surg Br. 2002;84:407–12.

81.

Price CT, Connolly JF, Carantzas AC, Ilyas I. Comparison of bone grafts for posterior spinal fusion in adolescent idiopathic scoliosis. Spine (Phila Pa 1976). 2003;28:793–8.

82.

Docquier PL, Delloye C. Treatment of simple bone cysts with aspiration and a single bone marrow injection. J Pediatr Orthop. 2003;23:766–73.PubMed

83.

Gangji V, Hauzeur JP, Matos C, et al. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Jt Surg Am. 2004;86-A:1153–60.

84.

Hernigou PH, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions: influence of the number and concentration of progenitor cells. J Bone Jt Surg A. 2005;87(7):1430–7.

85.

Kanellopoulos AD, Yiannakopoulos CK, Soucacos PN. Percutaneous reaming of simple bone cysts in children followed by injection of demineralized bone matrix and autologous bone marrow. J Pediatr Orthop. 2005;25:671–5.PubMed

86.

Neen D, Noyes D, Shaw M, et al. Healos and bone marrow aspirate used for lumbar spine fusion: a case controlled study comparing healos with autograft. Spine (Phila Pa 1976). 2006;31:E636–E40.

87.

Yan ZQ, Chen YS, Li WJ, et al. Treatment of osteonecrosis of the femoral head by percutaneous decompression and autologous bone marrow mononuclear cell infusion. Chin J Traumatol. 2006;9:3–7.PubMed

88.

Deng G, Ling Q, Li T. Treatment of bone cyst by transplantation of autologous bone marrow combined with allograft bone. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007;21:801–3.PubMed

89.

Cho HS, Oh JH, Kim HS, et al. Unicameral bone cysts: a comparison of injection of steroid and grafting with autologous bone marrow. J Bone Jt Surg Br. 2007;89:222–6.

90.

Wright JG, Yandow S, Donaldson S, et al. A randomized clinical trial comparing intralesional bone marrow and steroid injections for simple bone cysts. J Bone Jt Surg Am. 2008;90:722–30.

91.

Park IH, Micic ID, Jeon IH. A study of 23 unicameral bone cysts of the calcaneus: open chip allogeneic bone graft versus percutaneous injection of bone powder with autogenous bone marrow. Foot Ankle Int. 2008;29:164–70.PubMed

92.

Gan Y, Dai K, Zhang P, et al. The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion. Biomaterials. 2008;29:3973–82.PubMed

93.

Zamzam MM, Abak AA, Bakarman KA, et al. Efficacy of aspiration and autogenous bone marrow injection in the treatment of simple bone cysts. Int Orthop. 2009;33:1353–8.PubMed

94.

Sir M, Prochazka V, Gumulec J, et al. Our first experiences with autologous transplantation of bone marrow stem cells to treat pseudarthrosis, delayed fracture healing and long bone defects fracture. Vnitr Lek. 2009;55:187–9.PubMed

95.

Kitoh H, Kawasumi M, Kaneko H, Ishiguro N. Differential effects of culture-expanded bone marrow cells on the regeneration of bone between the femoral and the tibial lengthenings. J Pediatr Orthop. 2009;29:643–9.PubMed

96.

Hernigou P, Poignard A, Zilber S, Rouard H. Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop. 2009;43:40–5.PubMedPubMedCentral

97.

Wang BL, Sun W, Shi ZC, et al. Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononu-clear cells. Arch Orthop Trauma Surg. 2010;130:859–65.PubMed

98.

Miller MA, Ivkovic A, Porter R, et al. Autologous bone grafting on steroids: preliminary clinical results. A novel treatment for nonunions and segmental bone defects. Int Orthop. 2010;35:599–605PubMedPubMedCentral

99.

Yamasaki T, Yasunaga Y, Ishikawa M, et al. Bone-marrow-derived mononuclear cells with a porous hydroxyapatite scaffold for the treatment of osteonecrosis of the femoral head: a preliminary study. J Bone Jt Surg Br. 2010;92:337–41.

100.

Gessmann J, Köller M, Godry H, Schildhauer TA, Seybold D. Regenerate augmentation with bone marrow concentrate after traumatic bone loss. Orthop Rev (Pavia) 2012;4(1):e14. (Epub 2012 Mar 27).PubMedCentral

101.

Kassem MS. Percutaneous autogenous bone marrow injection for delayed union or non union of fractures after internal fixation. Acta Orthop Belg. 2013;79:711–7.PubMed

102.

Lee DH, Ryu KJ, Kim JW, Kang KC, Choi YR. Bone marrow aspirate concentrate and platelet-rich plasma enhanced bone healing in distraction osteogenesis of the tibia. Clin Orthop Relat Res. 2014;472:3789–97.PubMedPubMedCentral

103.

Desai P, Hasan SM, Zambrana L, Hegde V, Saleh A, Cohn MR. Lane JM Bone mesenchymal stem cells with growth factors successfully treat nonunions and delayed unions. HSS J. 2015;11(2):104–11.PubMedPubMedCentral

104.

Hernigou P, Guissou I, Homma Y, Poignard A, Chevallier N, Rouard H, et al. Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes. Int Orthop. 2015;39:1639–43.PubMed

Title: Autologous cell-based therapy for treatment of large bone defects: from bench to bedside
Authors: R. Verboket
M. Leiblein
C. Seebach
C. Nau
M. Janko
M. Bellen
H. Bönig
D. Henrich
I. Marzi
Publication date: 01-10-2018
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Trauma and Emergency Surgery / Issue 5/2018
Print ISSN: 1863-9933
Electronic ISSN: 1863-9941
DOI: https://doi.org/10.1007/s00068-018-0906-y

2024 ASCO Annual Meeting

Springer Medicine

Autologous cell-based therapy for treatment of large bone defects: from bench to bedside

Abstract

Objectives

Methods

Results

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Objectives

Methods

Results

Please log in to get access to this content

Other articles of this Issue 5/2018

Early local microcirculation is improved after intramedullary nailing in comparison to external fixation in a porcine model with a femur fracture

Using IL-6 concentrations in the first 24 h following trauma to predict immunological complications and mortality in trauma patients: a meta-analysis

Short- and long-term outcomes of surgical management of peptic ulcer complications in the era of proton pump inhibitors

Proposal of a new preliminary scoring tool for early identification of significant blunt bowel and mesenteric injuries in patients at risk after road traffic crashes

Physical therapists as first-line diagnosticians for traumatic acute rotator cuff tears: a prospective study

Diagnostics and early treatment in prehospital and emergency-room phase in suspicious pelvic ring fractures